. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: Mol Cancer Ther. 2015 May 12;14(7):1717–1727. doi: 10.1158/1535-7163.MCT-14-0607

Table 1.

Number of tumors initiated from CD24+ and CD24− cell populations from cell line and primary tumors for each cell number. Cells were in contralateral flanks of NOG mice and monitored up to 3 months.

	Cell Source
	Tumor Cell line		Primary Tumors
Number of cells injected	Tumors formed from CD24+	Tumors formed from CD24(−)	Tumors formed from CD24+	Tumors formed from CD24(−)
50,000^*	ND	ND	11/15	6/15
5000^*	5/5	5/5	2/10	1/10
1500	5/5	3/5	ND	ND
600	4/5	3/5	ND	ND
200	5/5	2/5	ND	ND
200^^	9/10	5/10	ND	ND

Cells injected into separate mice and monitored up to 5 months.